290 related articles for article (PubMed ID: 31827635)
1. Plasma Fibrin Clot Properties Are Unfavorably Altered in Women following Venous Thromboembolism Associated with Combined Hormonal Contraception.
Piróg M; Piwowarczyk S; Undas A
Dis Markers; 2019; 2019():4923535. PubMed ID: 31827635
[TBL] [Abstract][Full Text] [Related]
2. Prothrombotic fibrin clot properties are associated with post-discharge venous thromboembolism in acutely ill medical patients.
Wójcik M; Zaręba L; Undas A
Thromb Res; 2019 Oct; 182():141-149. PubMed ID: 31479942
[TBL] [Abstract][Full Text] [Related]
3. Prothrombotic fibrin clot properties associated with increased endogenous thrombin potential and soluble P-selectin predict occult cancer after unprovoked venous thromboembolism.
Mrozinska S; Cieslik J; Broniatowska E; Malinowski KP; Undas A
J Thromb Haemost; 2019 Nov; 17(11):1912-1922. PubMed ID: 31323706
[TBL] [Abstract][Full Text] [Related]
4. Unfavorably altered plasma clot properties in women with a HERDOO2 score equal to or greater than 2 and prediction of recurrent venous thromboembolism.
Mrozińska S; Cieślik J; Broniatowska E; Undas A
Pol Arch Intern Med; 2018 Oct; 128(10):572-579. PubMed ID: 30113019
[TBL] [Abstract][Full Text] [Related]
5. Fibrin clot properties in women heterozygous for factor V Leiden mutation: effects of oral contraceptives.
Krzek M; Ciesla-Dul M; Zabczyk M; Undas A
Thromb Res; 2012 Oct; 130(4):e216-21. PubMed ID: 22940058
[TBL] [Abstract][Full Text] [Related]
6. Prothrombotic Fibrin Clot Phenotype Is Associated With Recurrent Pulmonary Embolism After Discontinuation of Anticoagulant Therapy.
Zabczyk M; Plens K; Wojtowicz W; Undas A
Arterioscler Thromb Vasc Biol; 2017 Feb; 37(2):365-373. PubMed ID: 28062504
[TBL] [Abstract][Full Text] [Related]
7. Altered Plasma Clot Properties and Trauma-Related Venous Thromboembolism despite Thromboprophylaxis.
Goldman S; Frączek P; Szklanny K; Papuga-Szela E; Stanisz A; Undas A
Thromb Haemost; 2018 Apr; 118(4):654-663. PubMed ID: 29618152
[TBL] [Abstract][Full Text] [Related]
8. Altered plasma fibrin clot properties and fibrinolysis in patients with multiple myeloma.
Undas A; Zubkiewicz-Usnarska L; Helbig G; Woszczyk D; Kozińska J; Dmoszyńska A; Podolak-Dawidziak M; Kuliczkowski K
Eur J Clin Invest; 2014 Jun; 44(6):557-66. PubMed ID: 24738991
[TBL] [Abstract][Full Text] [Related]
9. Reduced plasma fibrin clot permeability and susceptibility to lysis are associated with increased risk of postthrombotic syndrome.
Siudut J; Grela M; Wypasek E; Plens K; Undas A
J Thromb Haemost; 2016 Apr; 14(4):784-93. PubMed ID: 26786481
[TBL] [Abstract][Full Text] [Related]
10. Plasma fibrin clot properties in the G20210A prothrombin mutation carriers following venous thromboembolism: the effect of rivaroxaban.
Janion-Sadowska A; Natorska J; Siudut J; Ząbczyk M; Stanisz A; Undas A
Thromb Haemost; 2017 Aug; 117(9):1739-1749. PubMed ID: 28771277
[TBL] [Abstract][Full Text] [Related]
11. Prolonged duration of type 2 diabetes is associated with increased thrombin generation, prothrombotic fibrin clot phenotype and impaired fibrinolysis.
Konieczynska M; Fil K; Bazanek M; Undas A
Thromb Haemost; 2014 Apr; 111(4):685-93. PubMed ID: 24306139
[TBL] [Abstract][Full Text] [Related]
12. Denser plasma clot formation and impaired fibrinolysis in paroxysmal and persistent atrial fibrillation while on sinus rhythm: association with thrombin generation, endothelial injury and platelet activation.
Drabik L; Wołkow P; Undas A
Thromb Res; 2015 Aug; 136(2):408-14. PubMed ID: 26048399
[TBL] [Abstract][Full Text] [Related]
13. Fibrin clot characteristics in acute ischaemic stroke patients treated with thrombolysis: the impact on clinical outcome.
Bembenek JP; Niewada M; Siudut J; Plens K; Członkowska A; Undas A
Thromb Haemost; 2017 Jun; 117(7):1440-1447. PubMed ID: 28382369
[TBL] [Abstract][Full Text] [Related]
14. Induction therapy alters plasma fibrin clot properties in multiple myeloma patients: association with thromboembolic complications.
Undas A; Zubkiewicz-Usnarska L; Helbig G; Woszczyk D; Kozińska J; Dmoszyńska A; Dębski J; Podolak-Dawidziak M; Kuliczkowski K
Blood Coagul Fibrinolysis; 2015 Sep; 26(6):621-7. PubMed ID: 26083985
[TBL] [Abstract][Full Text] [Related]
15. Altered plasma clot properties increase the risk of recurrent deep vein thrombosis: a cohort study.
Cieslik J; Mrozinska S; Broniatowska E; Undas A
Blood; 2018 Feb; 131(7):797-807. PubMed ID: 29242187
[TBL] [Abstract][Full Text] [Related]
16. Unfavourably altered plasma clot properties in patients with primary Raynaud's phenomenon: association with venous thromboembolism.
Żuk J; Snarska-Drygalska A; Malinowski KP; Papuga-Szela E; Natorska J; Undas A
J Thromb Thrombolysis; 2019 Feb; 47(2):248-254. PubMed ID: 30684190
[TBL] [Abstract][Full Text] [Related]
17. Does cell-free DNA promote coagulation and inhibit fibrinolysis in patients with unprovoked venous thromboembolism?
Medeiros SK; Emery B; Bhagirath V; Parpia S; Dwivedi DJ; Dwivedi NJ; Kearon C; Liaw PC
Thromb Res; 2020 Feb; 186():13-19. PubMed ID: 31838139
[TBL] [Abstract][Full Text] [Related]
18. Increased plasma clot permeability and susceptibility to lysis are associated with heavy menstrual bleeding of unknown cause: a case-control study.
Szczepaniak P; Zabczyk M; Undas A
PLoS One; 2015; 10(4):e0125069. PubMed ID: 25909989
[TBL] [Abstract][Full Text] [Related]
19. Prothrombotic fibrin clot properties associated with NETs formation characterize acute pulmonary embolism patients with higher mortality risk.
Ząbczyk M; Natorska J; Janion-Sadowska A; Metzgier-Gumiela A; Polak M; Plens K; Janion M; Skonieczny G; Mizia-Stec K; Undas A
Sci Rep; 2020 Jul; 10(1):11433. PubMed ID: 32651425
[TBL] [Abstract][Full Text] [Related]
20. Unfavorably Altered Fibrin Clot Properties in Patients with Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome): Association with Thrombin Generation and Eosinophilia.
Mastalerz L; Celińska-Lӧwenhoff M; Krawiec P; Batko B; Tłustochowicz W; Undas A
PLoS One; 2015; 10(11):e0142167. PubMed ID: 26540111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
